Meta develops Llama 4 to enhance conversational AI

Meta is advancing its AI technology with the development of Llama 4, a new large language model aimed at improving conversational interactions. This move positions Meta in competition with companies like OpenAI and Google in enhancing user experiences on digital platforms. Manchester's life sciences sector is thriving, with business growth outpacing the national average despite AstraZeneca's departure in 2013. The city has become a hub for over 200 companies, benefiting from affordability and strong graduate retention, while facing challenges in venture capital availability. Roche has entered a $5.3 billion licensing deal with Zealand Pharma to develop a new obesity drug, petrelintide. This strategic alliance aims to strengthen Roche's market position against competitors like Eli Lilly and Novo Nordisk, focusing on improved patient experiences.